European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive
Links shared publicly online about this topic.
- 776total visits
European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed all available data on Invirase (saquinavir) and the potential risk of arrhythmia, and concluded t
View full resource at medicalnewstoday.com
Tags: Heart Disease, Arrhythmia, HIV Medication, Invirase
Most Recently Shared on October 25, 2010 at 12:05 pm By:
European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive http://mnt.to/3LDR #hivaids
Also Shared By:
Advertisement
Heart Health
@HeartsHealth
MedicalNewsToday: European Medicines Agency Concludes That Benefit-risk Balance Of Invirase: http://bit.ly/95ph0o Full http://bit.ly/ctj2iu
1 year ago...